Medicine and Health Sciences Commons^™

Peptide Functionalized Surfactant Msns, Sonia Barrett

Kansas State University Undergraduate Research Conference

Antibiotic resistance in bacteria has become a rising problem since the first antibiotic was created, further aggravated by the improper overuse to treat common infections, because of this pharmaceutical companies must keep making new and stronger antibiotics. Surfactants are plentiful and effective killers of many surface bacteria and are also varied in their structure, all have a hydrophilic head and long hydrophobic carbon chain. These long hydrophobic carbon chains can pierce through the lipid bilayers that make up bacteria cell membranes and cause cytoplasmic leakage and lysis of the cell wall, leading to cell death. One proposed surfactant is synthesized …

Peptide Conjugation Of Branched Amphiphilic Peptide Capsules, Baltazar Claro-Martinez

Kansas State University Undergraduate Research Conference

In recent years, nanocarrier cellular therapy has been a rapidly growing area for research in the treatment of malignant and infectious diseases – most notably cancer. Conventional cancer treatment has consisted of highly toxic, highly insoluble, untargeted delivery of drugs that kill both cancerous and healthy cells. Research in the Tomich lab consists of the synthesis of Branched Amphiphilic Peptide Capsules (BAPCs), which are self-assembling peptide nanospheres composed of one or both of these branched peptide sequences: h5 and h9. These peptides possess similar molecular characteristics of phosphoglycerides but are synthesized chemically within the lab. Previous publications by the Tomich …

Therapeutic Peptide Sequences And Gatekeepers Loaded With Mesoporous Silica Nanoparticles, Dursitu Hassen

Kansas State University Undergraduate Research Conference

The research community is developing and looking into new ways of effectively delivering anti-cancer treatment. According to National Cancer Institute over 1.5 million new cases of cancer are predicted in the United States, just alone in 2018. The major hurdles that have been identified by scientists are finding mechanisms that assist in decreasing the side effects of cancer treatment and to increase the effectiveness of the drug. In our lab, a highly toxic peptide sequence, SA-K₆L₉-AS is encapsulated in MSNs (mesoporous silica nanoparticles) and capped with a gatekeeper. The function of a gatekeeper is preventing the …

Developing A Technique Using Peptide And Dye Synthesis For Cancer Research, Vanessa Hernandez

Kansas State University Undergraduate Research Conference

Developing a Technique Using Peptide and Dye Synthesis for Cancer Research

Vanessa Hernandez, Obdulia Covarrubias Zambrano, Stefan H. Bossmann

Department of Chemistry, College of Arts and Sciences, Kansas State University

Cancer occurs when a mutated single cell continues to divide uncontrollably, developing into one of the 200 different cancer types. Cancer is the second leading cause of death in the United States, with approximately 1.8 million new cases occurring this year. Current cancer detection and treatment techniques are costly and not optimal, due to the lack of cancer specificity as well as early detection achieved in some cancer types. This …

Production And Purification Of Aromatase For Co-Crystallization, Bryant Avila

Kansas State University Undergraduate Research Conference

Aromatase (CYP19) is an enzyme that converts androgens into estrogens. It is a drug target to treat hormone-dependent breast cancer, yet current therapeutics often result in patient health deterioration due to unwanted side effects. We want to recombinantly express high yields of stable aromatase to co-crystallize with our new, potent inhibitors. These crystals will be used to produce a 3-D structure to visualize the protein-inhibitor complex. We hope that the structure will help us understand the interactions that are essential for drug potency. We currently produce 1 mg/mL of protein. We hope to increase the stability with mutants A419S, G156A, …